Alnylam Pharmaceuticals
ALNY
#631
Rank
$40.31 B
Marketcap
$301.98
Share price
-1.01%
Change (1 day)
-0.85%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Quarterly Reports

Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q4

Quarterly Report 2025-q4

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report